↓ Skip to main content

Neuropharmacology of New Psychoactive Substances (NPS)

Overview of attention for book
Cover of 'Neuropharmacology of New Psychoactive Substances (NPS)'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 15 NPS: Medical Consequences Associated with Their Intake
  3. Altmetric Badge
    Chapter 16 Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
  4. Altmetric Badge
    Chapter 17 Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.
  5. Altmetric Badge
    Chapter 18 Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
  6. Altmetric Badge
    Chapter 20 Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
  7. Altmetric Badge
    Chapter 21 Neurotoxicology of Synthetic Cathinone Analogs.
  8. Altmetric Badge
    Chapter 32 The Affective Properties of Synthetic Cathinones: Role of Reward and Aversion in Their Abuse.
  9. Altmetric Badge
    Chapter 33 Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.
  10. Altmetric Badge
    Chapter 34 The Growing Problem of New Psychoactive Substances (NPS).
  11. Altmetric Badge
    Chapter 35 MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
  12. Altmetric Badge
    Chapter 39 Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
  13. Altmetric Badge
    Chapter 41 Structure-Activity Relationships of Synthetic Cathinones.
  14. Altmetric Badge
    Chapter 53 Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
  15. Altmetric Badge
    Chapter 54 Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.
  16. Altmetric Badge
    Chapter 60 Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites
  17. Altmetric Badge
    Chapter 61 Clinical Pharmacology of the Synthetic Cathinone Mephedrone.
  18. Altmetric Badge
    Chapter 63 Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters
  19. Altmetric Badge
    Chapter 64 Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 512)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
3 news outlets
blogs
2 blogs
policy
1 policy source
twitter
20 X users
facebook
4 Facebook pages
wikipedia
26 Wikipedia pages

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuropharmacology of New Psychoactive Substances (NPS)
Published by
Current topics in behavioral neurosciences, January 2017
DOI 10.1007/978-3-319-52444-3
ISBNs
978-3-31-952442-9, 978-3-31-952444-3
Editors

Michael H. Baumann, Richard A. Glennon, Jenny L. Wiley

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 22%
Student > Ph. D. Student 5 16%
Student > Bachelor 4 13%
Student > Doctoral Student 3 9%
Student > Master 3 9%
Other 5 16%
Unknown 5 16%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 19%
Medicine and Dentistry 5 16%
Neuroscience 5 16%
Psychology 3 9%
Chemistry 3 9%
Other 3 9%
Unknown 7 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2023.
All research outputs
#798,692
of 24,739,153 outputs
Outputs from Current topics in behavioral neurosciences
#29
of 512 outputs
Outputs of similar age
#17,361
of 430,945 outputs
Outputs of similar age from Current topics in behavioral neurosciences
#4
of 40 outputs
Altmetric has tracked 24,739,153 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 512 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,945 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.